Company Overview of KeraCure, Inc.
KeraCure, Inc. develops and commercializes a wound healing technology that is designed to improve the natural regenerative process of the human body. It offers KeraPac, a living tissue that stimulates the body’s own natural healing process by activating its ability to repair and regenerate tissue. The company’s clinical product pipeline covers chronic wounds for additional regenerative medicine applications, including bone restoration and nerve regeneration. Its products are also used as a primary therapy for diabetic foot ulcers and other chronic wounds. The company was founded in 1999 and is based in Chicago, Illinois.
101 North Wacker Drive
Chicago, IL 60606
Founded in 1999
Key Executives for KeraCure, Inc.
Similar Private Companies By Industry
|Phoenix Pharmacologics, Inc.||United States|
|Porton International, Inc.||United States|
|CymoGen Dx, LLC||United States|
|N. American Chem. Corp.||United States|
|ImmuneRegen BioSciences, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact KeraCure, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.